secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2026-09-14T20:35:23+00:00
Accession:  0001493152-26-042592
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech converts $400K debt to 1.75M shares at $0.228 per share
----------------------------------------------------------------------

- Converted $400,000 of Nov 18, 2025 promissory note into 1,749,434 shares at avg $0.228/share via two exchange agreements.
- Shares issued to Streeterville Capital under Section 3(a)(9) exemption; no cash consideration; reduces outstanding note balance.
- Stockholders approved conversion at July 15, 2026 special meeting per NYSE American Company Guide Sections 713(a)/(b).
- Original note principal $3,301,250; remaining balance outstanding after conversion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315226042592/0001493152-26-042592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315226042592/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer